Schedule 13G ownership disclosure
Akers Biosciences Inc
Security class unavailable · CUSIP: 00973E102
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,216,831
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001393825-18-000008
- Form type
- SC 13G
- Filer
- Q/C TECHNOLOGIES, INC.
- CIK
- CIK 1321834
- Filed
- Feb 01, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership